Myriad Genetics | MYGN - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Agilent USD 25M 0 2026-03
Becton, Dickinson and Co. USD 149M 4M 2026-03
Bio-Rad Laboratories USD 12.1M 200K 2025-12
Bruker USD 8.1M 11.9M 2025-12
Danaher USD 63M 8M 2026-03
Illumina USD 26M 1000K 2025-12
J&J USD 43M 25M 2026-03
Mettler Toledo International USD 17.39M 307K 2025-12
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Quidel USD 5.63B 5.58B 2026-03
Repligen USD 5.58M 83K 2026-03
Revvity USD 24.72M 1.2M 2026-03
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 354M 11M 2026-03
Veracyte USD 2K 1000 2023-12
Waters USD 42M 33.38M 2026-03